Hinz, Boris http://orcid.org/0000-0002-0526-393X
Lagares, David http://orcid.org/0000-0002-7317-8796
Article History
Accepted: 4 October 2019
First Online: 2 December 2019
Competing interests
: D.L. declares that he has received research funding from Boehringer Ingelheim, Indalo Therapeutics and Unity Biotechnology. D.L. also has a financial interest in Mediar Therpeutics, which is developing treatments for organ fibrosis. D.L.’s interests were reviewed and are managed by MGH and Partners HealthCare in accordance with their conflict of interest policies. B.H. declares no competing interests.